
    
      This study composes two parts. The first is a 24-week period during which subjects receive
      designed treatment regimen; after that, subjects will be informed again for the next 24-week
      regimen (extention phase) and can choose whether or not to participate in the treatment (with
      the same regimen in the first period) voluntarily.
    
  